The FDA approval comes without a controlled clinical trial, which is usually required for a regulatory OK. But in studies, Velcade clearly helped a third of multiple myeloma patients who had failed two or more previous therapies--a stunning result in such a lethal disease.

FORBES: Millennium's Short Road For Velcade Approval